Authors :
A SAI THANMAYE; DR. SHUBHAM GUPTA; DR. SALMAN KHURSHID SHAH; ABHINAVA S; DR. GAYATHRI T
Volume/Issue :
Volume 7 - 2022, Issue 6 - June
Google Scholar :
https://bit.ly/3IIfn9N
Scribd :
https://bit.ly/3ORKkfh
DOI :
https://doi.org/10.5281/zenodo.6692397
Abstract :
Of all the malignancies to exist, breast
cancer is and continues to be one of the most pervasive
cancers. For the first time, female breast cancer was the
most commonly diagnosed cancer surpassing lung cancer
as reported by the American Cancer Society (ACS) and
the International Agency for Research on Cancer
(IARC) of 2020. Breast cancer is considered to be a
heterogeneous disease due to its presentation of a wide
variety of morphological, histopathological and
biological features. Aim of the Study: To analyse the
concordance of ultrasound findings of BI-RADS
categories 2, 3, 4 and 5 lesions with histopathological
biopsy results and calculate the predictive value and
diagnostic accuracy of BIRADS. Materials and methods:
It isa retrospective study, data were collected over a
period of 5 years, from 2016 to 2020. Data from a total of
190 patients with related symptomatology and breast
lumps who underwent ultrasound examination by expert
radiologists were collected. The data were also correlated
with pathological findings for those patients who
underwent biopsy, the two were correlated. Results:
BIRADS Lexicon had a high sensitivity of 95.23%, and
the specificity and diagnostic accuracy were calculated to
be 92.78% and 94.89% each respectively. BIRADS 2&3
had a high NPV of 97.82% and 4 and 5 had a PPV of
85.10%. The fact that there is a relatively high NPV for
the lower BIRADS categories can be exploited and
biopsies can be largely avoided in these cases. The high
sensitivity of the BIRADS lexicon makes ultrasound a
close alternative for mammography in the preliminary
screening of breast lesions
Of all the malignancies to exist, breast
cancer is and continues to be one of the most pervasive
cancers. For the first time, female breast cancer was the
most commonly diagnosed cancer surpassing lung cancer
as reported by the American Cancer Society (ACS) and
the International Agency for Research on Cancer
(IARC) of 2020. Breast cancer is considered to be a
heterogeneous disease due to its presentation of a wide
variety of morphological, histopathological and
biological features. Aim of the Study: To analyse the
concordance of ultrasound findings of BI-RADS
categories 2, 3, 4 and 5 lesions with histopathological
biopsy results and calculate the predictive value and
diagnostic accuracy of BIRADS. Materials and methods:
It isa retrospective study, data were collected over a
period of 5 years, from 2016 to 2020. Data from a total of
190 patients with related symptomatology and breast
lumps who underwent ultrasound examination by expert
radiologists were collected. The data were also correlated
with pathological findings for those patients who
underwent biopsy, the two were correlated. Results:
BIRADS Lexicon had a high sensitivity of 95.23%, and
the specificity and diagnostic accuracy were calculated to
be 92.78% and 94.89% each respectively. BIRADS 2&3
had a high NPV of 97.82% and 4 and 5 had a PPV of
85.10%. The fact that there is a relatively high NPV for
the lower BIRADS categories can be exploited and
biopsies can be largely avoided in these cases. The high
sensitivity of the BIRADS lexicon makes ultrasound a
close alternative for mammography in the preliminary
screening of breast lesions